Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method
about
Manufacturing of recombinant adeno-associated viral vectors for clinical trialsChallenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene TherapyProgress with Recombinant Adeno-Associated Virus Vectors for Gene Therapy of Alpha-1 Antitrypsin DeficiencyA review of augmentation therapy for alpha-1 antitrypsin deficiency.Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes.Assessment of toxicity and biodistribution of recombinant AAV8 vector-mediated immunomodulatory gene therapy in mice with Pompe disease.Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results.Safety and biodistribution assessment of sc-rAAV2.5IL-1Ra administered via intra-articular injection in a mono-iodoacetate-induced osteoarthritis rat modelSafety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin.Progress and challenges in viral vector manufacturingSafety and Biodistribution Evaluation in Cynomolgus Macaques of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of AchromatopsiaPreclinical safety evaluation of recombinant adeno-associated virus 2 vector encoding human tumor necrosis factor receptor-immunoglobulin Fc fusion geneHuman Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression.Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle.Gene therapy for alpha-1 antitrypsin deficiency.The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency.Recent advances in α-1-antitrypsin deficiency-related lung disease.Current status of gene therapy for α-1 antitrypsin deficiency.Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.A scalable method for the production of high-titer and high-quality adeno-associated type 9 vectors using the HSV platform.Safety and Efficacy of AAV5 Vectors Expressing Human or Canine CNGB3 in CNGB3-Mutant Dogs.α1-Antitrypsin deficiency.Pharmacology of Recombinant Adeno-associated Virus Production.
P2860
Q26750799-F69AD2BE-EDC0-4FCF-B73F-F47D7F8C7A1EQ28080450-B6110EEF-47CC-4379-8103-75D5407EAFE3Q28085148-005B76F1-D824-4860-96F4-84AEDFC2CC8AQ34268108-A7993BAB-CB34-4476-A677-12D6BDD37DD6Q35063726-92F9D0C3-1C83-4027-9F3D-96028036D858Q35184237-366B2CE8-198E-4053-8FA2-1E832CD7B337Q35496285-9A43C303-E816-4A4C-9957-1E7F8B0588D7Q36466909-CAC43E3C-150D-4A37-BAAC-B7BCDCC89DF6Q36677162-E2DBBE05-3B1F-4F11-805D-215D20858FF0Q36713761-3B721307-8A4B-4E70-A2DD-FEA640878B3BQ36852206-955CD610-96FB-4283-ACFA-8AAF411963B8Q37134964-DE9BABA6-4F54-4F1F-94CE-0C0CC5B35072Q37384103-B01FA02E-5125-4E0D-A891-B760B4847F6FQ37731874-EF366136-6D12-4944-BEE3-D20786C77F37Q37866000-BA40C71C-B5A4-4EE6-9093-825B9134D962Q37894093-A24B5FFE-B376-42BD-A7FB-72752FD04005Q38111790-2DB0F68A-C8C8-4FD1-80FB-10F85CD66EA2Q38264336-6D55E9D9-5CFD-4CAC-A039-B71533359A4CQ38937862-F5D28C5F-91CF-4974-AF13-4CFC5FD29637Q39737661-095C8510-6542-463A-88E2-38EBC4A10412Q45873049-623FEF01-EB42-47B0-B603-7BFB157EE24FQ51481224-3326427D-7FC2-4F42-AECB-4D9F8AA7220DQ52717185-C8A471E7-684C-4DA8-9AB1-392ECFD473AC
P2860
Preclinical evaluation of a recombinant adeno-associated virus vector expressing human alpha-1 antitrypsin made using a recombinant herpes simplex virus production method
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Preclinical evaluation of a re ...... implex virus production method
@ast
Preclinical evaluation of a re ...... implex virus production method
@en
Preclinical evaluation of a re ...... implex virus production method
@nl
type
label
Preclinical evaluation of a re ...... implex virus production method
@ast
Preclinical evaluation of a re ...... implex virus production method
@en
Preclinical evaluation of a re ...... implex virus production method
@nl
prefLabel
Preclinical evaluation of a re ...... implex virus production method
@ast
Preclinical evaluation of a re ...... implex virus production method
@en
Preclinical evaluation of a re ...... implex virus production method
@nl
P2093
P2860
P356
P1433
P1476
Preclinical evaluation of a re ...... implex virus production method
@en
P2093
Darby L Thomas
David R Knop
Gensheng Wang
Guo-Jie Ye
Janet M Benson
Jeffrey D Chulay
Julie A Hutt
Margaret Humphries
Terence R Flotte
P2860
P304
P356
10.1089/HUM.2010.118
P577
2010-12-12T00:00:00Z